MX359084B - Péptidos antimicrobianos. - Google Patents

Péptidos antimicrobianos.

Info

Publication number
MX359084B
MX359084B MX2014010655A MX2014010655A MX359084B MX 359084 B MX359084 B MX 359084B MX 2014010655 A MX2014010655 A MX 2014010655A MX 2014010655 A MX2014010655 A MX 2014010655A MX 359084 B MX359084 B MX 359084B
Authority
MX
Mexico
Prior art keywords
peptide
antimicrobial peptides
ter2
ter1
fungi
Prior art date
Application number
MX2014010655A
Other languages
English (en)
Other versions
MX2014010655A (es
Inventor
Wehkamp Jan
Schroeder Bjoern
Stange Eduard
Original Assignee
Robert Bosch Ges Fuer Medizinische Forschung Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Bosch Ges Fuer Medizinische Forschung Mbh filed Critical Robert Bosch Ges Fuer Medizinische Forschung Mbh
Publication of MX2014010655A publication Critical patent/MX2014010655A/es
Publication of MX359084B publication Critical patent/MX359084B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/98—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving alcohol, e.g. ethanol in breath
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)

Abstract

La presente invención se refiere a un nuevo péptido antimicrobiano, que presenta al menos ocho aminoácidos sucesivos, teniendo el péptido una secuencia con la siguiente fórmula: Ter1-X1-B1-X2-B2-X3-Z1-Z2-X4-Ter2. El péptido puede presentar además también extremos terminales modificados. El péptido es eficaz para el tratamiento o la prevención de enfermedades inflamatorias e infecciosas, que se provocan por microorganismos, tales como bacterias u hongos.
MX2014010655A 2012-03-07 2013-03-07 Péptidos antimicrobianos. MX359084B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012203547A DE102012203547A1 (de) 2012-03-07 2012-03-07 Antimikrobielle Peptide
PCT/EP2013/054599 WO2013132005A1 (de) 2012-03-07 2013-03-07 Antimikrobielle peptide

Publications (2)

Publication Number Publication Date
MX2014010655A MX2014010655A (es) 2015-03-06
MX359084B true MX359084B (es) 2018-09-03

Family

ID=47710149

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014010655A MX359084B (es) 2012-03-07 2013-03-07 Péptidos antimicrobianos.

Country Status (12)

Country Link
US (2) US20150087579A1 (es)
EP (1) EP2822958B1 (es)
JP (2) JP6157514B2 (es)
KR (1) KR20140142700A (es)
CN (2) CN104245721A (es)
AU (1) AU2013229486B2 (es)
CA (1) CA2866520C (es)
CL (1) CL2014002180A1 (es)
DE (1) DE102012203547A1 (es)
MX (1) MX359084B (es)
RU (1) RU2660351C2 (es)
WO (1) WO2013132005A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012203547A1 (de) * 2012-03-07 2013-09-12 Robert Bosch Gesellschaft Für Medizinische Forschung Mbh Antimikrobielle Peptide
KR101804847B1 (ko) 2014-10-27 2017-12-07 경희대학교 산학협력단 항균 펩타이드 헥사머를 포함하는 구강 질환 예방 및 치료용 약학적 조성물 및 이의 용도
KR20180022971A (ko) 2015-07-02 2018-03-06 다나-파버 캔서 인스티튜트 인크. 안정화된 항미생물성 펩티드
WO2017151617A1 (en) 2016-02-29 2017-09-08 Dana-Farber Cancer Institute, Inc. Stapled intracellular-targeting antimicrobial peptides to treat infection
FR3052453B1 (fr) * 2016-06-14 2018-05-18 Sederma Peptide, composition le comprenant et utilisations notamment cosmetiques
CA3067047A1 (en) 2017-07-19 2019-01-24 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
KR102558956B1 (ko) * 2019-12-30 2023-07-24 주식회사 아이젤 양친매성 펩타이드 및 이를 포함하는 항균용 또는 항염증용 조성물
CN116234818A (zh) * 2020-09-14 2023-06-06 艾斯克勒斯生物有限责任公司 用于治疗耐药微生物的防御素片段衍生脂肽
KR20230122899A (ko) * 2022-02-15 2023-08-22 주식회사 나이벡 항균, 항염증 또는 조직재생능을 구비하는 펩타이드 및 이의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE362481T1 (de) * 1999-10-12 2007-06-15 Blis Technologies Ltd Lantibiotikum
WO2003070176A2 (en) * 2002-02-19 2003-08-28 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Modified defensins and their use
CN1183960C (zh) * 2003-02-27 2005-01-12 四川大学 双歧杆菌细胞壁蛋白在制药中的应用
US8071285B1 (en) * 2003-05-14 2011-12-06 Carl Henry Lawyer Zinc finger protein derivatives and methods of using same
KR20090111307A (ko) * 2006-07-03 2009-10-26 엑손히트 써라퓨틱스 에스에이 전립선 특이적 전사물 및 전립선암의 치료 및 진단에 사용되는 이의 용도
EP2046363A1 (en) * 2006-07-10 2009-04-15 Österreichische Akademie der Wissenschaften Antimicrobial peptides
EP2077274A1 (en) * 2008-01-02 2009-07-08 Ceinge Biotecnologie Avanzate s.c. a r.l. Synthetic analogs of human beta-defensins having antimicrobial, antiviral and chemotactic activity
EP2237684A2 (en) * 2008-01-08 2010-10-13 Akthelia Pharmaceuticals Agonists for antimicrobial peptide systems
WO2009117524A2 (en) * 2008-03-18 2009-09-24 The Regents Of The University Of California Sparse matrix system and method for identification of specific ligands or targets
DE102010040153A1 (de) * 2010-09-02 2012-03-08 Robert Bosch Gesellschaft Für Medizinische Forschung Mbh Stoffkombination zur Behandlung von entzündlichen oder infektiösen Erkrankungen
DE102012203547A1 (de) * 2012-03-07 2013-09-12 Robert Bosch Gesellschaft Für Medizinische Forschung Mbh Antimikrobielle Peptide

Also Published As

Publication number Publication date
CN104245721A (zh) 2014-12-24
EP2822958A1 (de) 2015-01-14
CL2014002180A1 (es) 2015-04-17
EP2822958B1 (de) 2018-12-19
CA2866520C (en) 2019-05-21
RU2014140231A (ru) 2016-04-27
JP2017148045A (ja) 2017-08-31
US20150087579A1 (en) 2015-03-26
KR20140142700A (ko) 2014-12-12
JP2015510874A (ja) 2015-04-13
AU2013229486A1 (en) 2014-10-23
CA2866520A1 (en) 2013-09-12
JP6157514B2 (ja) 2017-07-05
AU2013229486B2 (en) 2017-10-19
MX2014010655A (es) 2015-03-06
CN108822201A (zh) 2018-11-16
WO2013132005A1 (de) 2013-09-12
DE102012203547A1 (de) 2013-09-12
RU2660351C2 (ru) 2018-07-05
US20170073371A1 (en) 2017-03-16

Similar Documents

Publication Publication Date Title
MX2014010655A (es) Peptidos antimicrobianos.
MY162636A (en) Anti parisitic dihydroazole compounds and compositions comprising same
PH12015500347A1 (en) 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
NZ593892A (en) Antibiotic compositions for the treatment of gram negative infections
MX369056B (es) Prevención, interrupción y tratamiento de biopelículas con lisina de bacteriófago.
EA201101214A1 (ru) Полиеновые противогрибковые композиции
MX2015011193A (es) Compuestos antivirales.
MX2011006803A (es) Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas.
MX363478B (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.
MX2014015884A (es) Compuestos antivirales.
GB201118201D0 (en) Novel peptides
IN2014CN00572A (es)
MX2016007626A (es) Peptido antimicrobiano y usos del mismo.
SG10201900541QA (en) Derivatives of xanthone compounds
MX2011008179A (es) Peptidos para vacuna.
EA201290792A1 (ru) Пептиды для вакцины против аллергии на березу
MX2015001834A (es) Nuevos compuestos antibacterianos.
MX2015011198A (es) Compuestos antivirales.
GB2568440A (en) Modified factor H binding protein
MX2014001623A (es) Uso de la cardiotofina-1 para el tratamiento de enfermedades renales.
MX2012002299A (es) Uso de cetoenoles ciclicos contra bacterias fitopatogenas.
HK1199201A1 (en) Antimicrobial peptides for treatment of infectious diseases
MX363480B (es) Compuestos bacterianos que constan de un grupo heterocicloalquilo basado en nitrógeno que contiene un doble enlace unido a carbonilo que inhiben la enzima fabi.
IN2014DN05865A (es)
MX2015008373A (es) Peptidos antimicrobianos, composiciones que los comprende y usos.

Legal Events

Date Code Title Description
FG Grant or registration